A 56-year-old man with an end-stage ischemic cardiomyopathy and a HeartWare left ventricular assist device (VAD) presented to the hospital with multifocal pneumonia. His medical history was notable for paroxysmal atrial fibrillation, sinus node dysfunction, and ventricular tachycardia treated with a dual-chamber Boston Scientific implantable cardioverter defibrillator. His recent and current hospitalizations were notable for a series of alarms for inadequate VAD flows for which no explanation had been found.
Case Report
A 56-year-old man with an end-stage ischemic cardiomyopathy and a HeartWare left ventricular assist device (VAD) presented to the hospital with multifocal pneumonia. His medical history was notable for paroxysmal atrial fibrillation, sinus node dysfunction, and ventricular tachycardia treated with a dual-chamber Boston Scientific implantable cardioverter defibrillator. His recent and current hospitalizations were notable for a series of alarms for inadequate VAD flows for which no explanation had been found.
At baseline, the patient was pacemaker dependent because of sinus node dysfunction. While admitted to the cardiac intensive care unit, occasional ventricular ectopy was recorded that resulted in subsequent right ventricular (RV) pacing ( Figure 1 ). These paroxysms of RV pacing were associated with significant hemodynamic compromise ( Figure 2 ) including a decrease in the systemic blood pressure, pulse pressure, pulsatility index, and flow estimation recorded by the VAD control module and an increase in the central venous pressure with the development of prominent v waves. Transthoracic echocardiography performed during atrial and RV pacing demonstrated significant worsening of tricuspid regurgitation (TR). These hemodynamic metrics (including TR severity) improved with cessation of RV pacing.
As the patient's atrioventricular conduction was intact and his indication for a pacemaker was sinus node dysfunction, his device was reprogrammed to an atrial-only pacemaker mode. Pneumonia responded to antibiotic therapy, and the patient had no additional episodes of RV pacing-induced cardiac dysfunction or alarms related to VAD flow.
Discussion
This case highlights an example of repetitive nonreentrant ventriculoatrial synchrony (RNRVAS) leading to profound pacemaker syndrome and consequent hemodynamic compromise. RNRVAS is a pacemaker-mediated ventriculoatrial synchronous arrhythmia, akin to pacemaker-mediated tachycardia. RNRVAS is characterized by retrograde atrial activation within the post ventricular atrial refractory period and subsequent noncapture of atrial pacing because of atrial refractoriness. This effectively creates a loop in which noncaptured atrial pacing does not result in native conduction to the ventricles and results in demand ventricular pacing during a DDD mode. 1 In this patient, a ventricular depolarization ( Figure 1A ) occurred synchronously with atrial pacing during the post ventricular atrial refractory period eliciting the first demand ventricular paced beat in the RNRVAS cycle. Although switching the implantable cardioverter defibrillator from DDD to AAI pacing interrupted arrhythmia, reprogramming in a patient without intact AV conduction can be more challenging. In these situations, it may be necessary to lower the lower rate limit, shorten the AV delay, or shorten the post ventricular atrial refractory period. 2 This patient's profound intolerance to RV pacing provides a unique and striking example of RNRVAS. In most instances, RNRVAS is silent or manifest only as palpitations. On occasion, changes in arterial blood pressure have been associated with other forms of the pacemaker syndrome, although never specifically ascribed to RNRVAS. 3 This patient's presentation is notable for the observed significant hemodynamic effects associated with worsening TR and RV dysfunction ( Figure 2 ). It is unclear whether the changes in TR and RV function were because of the loss of AV synchrony, a change in ventricular contractile patterns because of ventricular pacing, or some combination of the 2. Although hemodynamic tracings with synchronous atrioventricular pacing would be necessary to make this distinction, they were not available.
The physiology and hemodynamics of pacing in VAD patients can be uniquely challenging to interpret. Compromised RV function associated with RV pacing may be because of dropout of left ventricular (LV) function because ≤65% of RV output is driven by LV contraction. 4 With previous generations of pulsatile pumps, cardiac output in patients Pacing With VAD with VADs was largely independent of LV contraction/synchrony, but with current-generation continuous-flow pumps, the LV contribution to VAD-augmented cardiac output may be much greater. In this patient with a continuous-flow LVAD, the switch from a narrow QRS to RV pacing likely induced enough intraventricular dyssynchrony to compromise RV output. This is evidenced by increased systemic venous pressure, increased TR, and decreased systemic arterial pulsatility (Figure 2A and 2B) . Diminished LV contractility manifests as decreased VAD flow variability ( Figure 2C, bottom) that coincides with the onset of RV pacing. Thus, the simultaneous hemodynamic changes observed with RV pacing (Figure 2A , 2B, and 2D) highlight how dependent the mechanics of RV contraction are on LV function.
In retrospect, the patient's unexplained VAD alarms during previous admissions were likely because of paroxysms of RNRVAS. Without an accurate diagnosis and subsequent implantable cardioverter defibrillator reprogramming, this iatrogenic arrhythmia would have continued to go undetected. In clinical situations such as this, unexplained changes in hemodynamics should result in a thorough investigation of all available data as to rule out device-based arrhythmias with simple solutions, such as RNRVAS. 
